Toggle light / dark theme

New methods enable scientists at IST Austria to take a look at the innermost of cells: High-resolution images of deep-frozen cells show structures that previously could only be guessed at.

The cells in our body are in motion. Some migrate from A to B to heal wounds or fight pathogens. They do so with the help of small “feet” at the leading edge of migrating cells, so-called lamellipodia. These thin extensions are pushed forward and bind to the surface while the rest of the cell is pulled along. Inside these feet is a dense network of interwoven protein threads, called actin filaments, which form the cell’s cytoskeleton. So far, it was unclear how the Arp2/3 complex, an assembly of seven proteins central for cell motility, sprouts off new actin filaments from pre-existing ones and thus generates dense, branched networks providing the required protrusive forces to the cell.

Until now, scientists had to decide when they wanted to analyze the structure of the Arp2/3 complex: One option was to study it in isolation, where the protein complex is in an inactive conformation and hence does not allow understanding of how the network is formed. In order to become fully activated, however, the Arp2/3 complex needs to be bound to actin filaments. This requires using a method called electron tomography, which comes at the cost of considerably lower resolution. “Previous electron tomography data of Arp2/3 complexes bound to actin filaments in a test-tube environment was too imprecise, making it impossible to unambiguously tell where the individual elements of the complex must be located,” explains Florian Fäßler, a postdoc in the group of IST Austria professor Florian Schur.

For those of us who don’t think that even our bowel movements will soon be inventoried, tracked and timestamped during every moment of existence, here is a just published white paper from the Rand Corporation, an influential think tank created in 1948 to offer research and analysis to the US military, which begs to differ.

The November 2020 whilte paper, published under the title “The Internet of Bodies,” focuses on the advantages and disadvantages, security and privacy risks, plus the ethical implications of what it calls a growing “Internet of Bodies (IoB).”

IoB tools are internet-connected “smart” devices increasingly available in the marketplace which promise to track and upload to the internet measurements related to individual heartbeat, blood pressure and other bodily functions in real time for purposes of health, exercise, security or other reasons.

In October, threat actors hit the Wyckoff Heights Medical Center in Brooklyn and the University of Vermont Health Network. The cyber attack took place on October 28 and disrupted services at the UVM Medical Center and affiliated facilities.

A month later, the University of Vermont Medical Center was continuing to recover from the cyber attack that paralyzed the systems at the Burlington hospital.

In early December, Hospital CEO Dr. Stephen Leffler announced that the attack that took place in late October on the computer systems of the University of Vermont Medical Center is costing the hospital about $1.5 million a day in lost revenue and recovery costs.

It looks like virtual education(which is happening more now) is actually preparing students for the workplace of the future.


That said, there may be a silver lining to virtual classrooms and distance learning, which many universities and schools this academic year are defaulting to, in various degrees, due to the coronavirus. As students and teachers may have to compensate for logistic challenges, collaborating online might prepare high school students with the kind of organizational acumen, emotional intelligence and self-discipline needed for modern careers, particularly those that allow for the growing trend of working in remote, distributed teams. The sooner that students master those proficiencies, the better off they’ll be when they reach the job market.

A 75-year-old man from Northern Israel died of a heart attack about two hours after being vaccinated against the novel coronavirus, the Health Ministry has confirmed. The man had pre-existing conditions and had suffered from heart attacks in the past, the ministry said. Health Ministry director-general Chezy Levy has launched an investigation into the incident. “We share in the grief of the family,” Levy said in a statement. The man was inoculated at around 8:30 a.m. at a Clalit clinic. He stayed at the facility, as is customary, for a short period of time to ensure he had no side effects. When he felt well, the clinic released him. Levy noted that the initial findings do not show a link between the man’s death and his vaccination. Recall that when Pfizer presented its safety data to the US Food and Drug Administration back in early December, it was found that two trial participants had died after receiving the vaccine.


A 75-year-old man from Beit She’an died of a heart attack about two hours after being vaccinated against the novel coronavirus on Monday morning, the Health Ministry reported. The man had preexisting conditions and had suffered from heart attacks in the past, it said. Health Ministry director-general Chezy Levy has launched an investigation into the incident. “We share in the grief of the family,” he said in a statement. The man was inoculated at around 8:30 a.m. at a Clalit Health Services clinic. He stayed at the facility, as is customary, for a short period of time to ensure he had no side effects. When he felt well, the clinic released him. The initial findings do not show a link between the man’s death and his vaccination, Levy said. When Pfizer presented its safety data to the US Food and Drug Administration in early December, it was found that two trial participants had died after receiving the vaccine. One of the deceased was immunocompromised, meaning the person’s immune defenses were low. In response to the report of those deaths, Israel’s Midaat Association said when vaccines are administered to at-risk populations, “there may be unfortunate cases. One should not infer from this about the safety of the vaccine, but welcome the transparency required from the pharma companies in the drug approval process.”

You want 2021 to be super. But not in a super gonorrhea type of way.

“Super gonorrhea” is trending on Twitter right now because, well, why not? It’s 2020, after all. And what better thing to have trend at the end of a year that brought us the Covid-19 coronavirus pandemic, a shortage of basically everything, constant drama in the White House, and a Presidential election that just won’t end? Consider this sexually transmitted infection to be the pie à la mode, the night cap, the final wipe of 2020.

This new anti-cancer drug will be attacking the mitochondria of cancer cells. They do this by inhibiting the enzyme mitochondrial RNA polymerase (POLRMT).

Differentiated tissues are said to be tolerant of the inhibition of this enzyme while rapidly proliferating cells are impacted more.


The compound was found to reduce tumor growth in mice.

People born without a corpus callosum do not have a bridge between the two cerebral hemispheres. Neuroscientists from UNIGE have shown how the brain manages to adapt.

One in 4000 people is born without a corpus callosum, a brain structure consisting of neural fibers that are used to transfer information from one hemisphere to the other. A quarter of these individuals do not have any symptoms, while the remainder either have low intelligence quotients or suffer from severe cognitive disorders. In a study published in the journal Cerebral Cortex, neuroscientists from the University of Geneva (UNIGE) discovered that when the neuronal fibers that act as a bridge between the hemispheres are missing, the brain reorganizes itself and creates an impressive number of connections inside each hemisphere. These create more intra-hemispheric connections than in a healthy brain, indicating that plasticity mechanisms are involved. It is thought that these mechanisms enable the brain to compensate for the losses by recreating connections to other brain regions using alternative neural pathways.

The corpus callosum develops in utero between the tenth and twentieth week of gestation. Agenesis of the corpus callosum is a congenital brain malformation in which this brain structure fails to develop, resulting in one out of 4000 babies born without a corpus callosum. When it is missing, nothing replaces this structure measuring about ten centimeters, with the exception of cerebrospinal fluid. This means that the information transmitted from one hemisphere to the other can no longer be conveyed by the neuronal projections from the corpus callosum. “Their role in a healthy brain,” begins Vanessa Siffredi, a researcher in UNIGE’s Faculty of Medicine, “is to ensure the functioning of various cognitive and sensorimotor functions.” Surprisingly, 25% of people with this malformation have no visible signs; 50% have average intelligence quotients and learning difficulties; and the remaining 25% suffer from severe cognitive disorders.